Letosteine
来托司坦
Report date: 2022/08/09 12:46:51
NME
Base Information
Drug NameLetosteine
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A
Develop Information
Other Information
ATC Code
Related LinksKEGG